MOTS-C vs Humanin: Mitochondrial Peptides Compared 2025

MOTS-C vs Humanin: Mitochondrial Peptides Compared 2025 MOTS-C vs Humanin Comparing Two Powerful Mitochondrial-Derived Peptides for Longevity Research MOTS-C and Humanin are both mitochondrial-derived peptides (MDPs) that have emerged as promising research compounds in the field of longevity and metabolic health. While they originate from mitochondrial DNA and share some overlapping benefits, they operate through distinct mechanisms and offer unique advantages for […] Comparing Two Powerful Mitochondrial-Derived Peptides for Longevity Research MOTS-C and Humanin are both mitochondrial-derived peptides (MDPs) that have emerged as promising research compounds in the field of longevity and metabolic health. While they originate from mitochondrial DNA and share some overlapping benefits, they operate through distinct mechanisms and offer unique advantages for different research applications. Full Name Mitochondrial Open Reading Frame of the 12S rRNA-c Humanin Amino Acid Length 16 amino acids 21-24 amino acids Discovery Year 2015 2001 Primary Target AMPK pathway, metabolic regulation STAT3 pathway, cellular protection Best Known For Metabolic enhancement, exercise mimetic, insulin sensitivity Neuroprotection, cardioprotection, anti-aging Research Dosage Range 5-15 mg per administration 2-10 mg per administration Half-Life ~30-60 minutes ~2-4 hours Primary Mechanism AMPK activation, metabolic switching STAT3 activation, apoptosis inhibition What It Is: MOTS-C is a 16-amino acid peptide encoded by the mitochondrial genome. It acts as a signaling molecule that regulates metabolic homeostasis and has been shown to enhance insulin sensitivity and metabolic flexibility. Primary Research Applications: Metabolic syndrome research Exercise performance studies Insulin resistance models Age-related metabolic decline Obesity and weight management research Skeletal muscle function What It Is: Humanin is a 21-24 amino acid peptide (depending on the isoform) encoded by mitochondrial DNA. It functions as a cytoprotective factor with potent anti-apoptotic and neuroprotective properties. Neurodegenerative disease models Cardiovascular protection research Alzheimer’s disease studies Cellular aging and senescence Diabetes-related complications Stroke and ischemia models MOTS-C operates primarily through metabolic pathways: AMPK Activation: Stimulates AMP-activated protein kinase, the cellular energy sensor Folate Metabolism: Regulates one-carbon metabolism and nucleotide biosynthesis Insulin Sensitivity: Enhances glucose uptake and insulin signaling Mitochondrial Function: Improves mitochondrial efficiency and biogenesis Gene Expression: Translocates to the nucleus under stress to regulate metabolic genes Humanin works through cellular protection pathways: STAT3 Activation: Activates the STAT3 signaling pathway for cell survival Anti-Apoptotic Effects: Inhibits cell death pathways (Bax, Bid) Neuroprotection: Protects neurons from Aβ toxicity and oxidative stress Insulin Signaling: Enhances insulin sensitivity in peripheral tissues Inflammation Reduction: Modulates inflammatory responses MOTS-C focuses on metabolic optimization and energy production, while Humanin emphasizes cellular protection and survival. Together, they represent mitochondria’s dual strategy: enhance function (MOTS-C) and protect cells (Humanin). Metabolic Enhancement: Superior for insulin sensitivity and glucose metabolism studies Exercise Performance: Acts as an exercise mimetic, enhancing physical performance in models Obesity Research: Shows promise in weight management and fat metabolism studies Skeletal Muscle: Enhances muscle function and endurance capacity Metabolic Syndrome: Addresses multiple components of metabolic dysfunction Neuroprotection: Unmatched for brain health and neurodegenerative disease models Cardioprotection: Protects heart tissue from ischemic injury Alzheimer’s Research: Shows specific benefits against Aβ toxicity Cellular Aging: Anti-aging effects through apoptosis inhibition Diabetes Complications: Protects against diabetic complications Improved insulin sensitivity by up to 28% in obese mouse models Enhanced exercise capacity and endurance in aged mice Prevented age-related insulin resistance in research studies Improved metabolic flexibility and substrate switching Reduced obesity-induced metabolic dysfunction Protected neurons from Aβ-induced toxicity in Alzheimer’s models Reduced infarct size by up to 30% in stroke models Improved cardiovascular outcomes in ischemia-reperfusion models Extended lifespan in certain research models Protected against diabetic complications in animal studies Research suggests combining MOTS-C and Humanin may offer synergistic benefits: Dual Protection: Metabolic enhancement + cellular protection Comprehensive Longevity: Addresses multiple aging pathways Mitochondrial Support: Function optimization + damage prevention Systemic Benefits: Covers both energy and survival aspects MOTS-C: 10 mg, 2-3x per week Humanin: 5 mg, 2-3x per week Duration: 8-12 weeks Administration: Subcutaneous injection Protocols vary based on research parameters. MOTS-C and Humanin represent two distinct but complementary approaches to mitochondrial health and longevity. MOTS-C excels in metabolic research and performance enhancement, while Humanin shines in cellular protection and neuroprotection studies. For comprehensive longevity research, combining both peptides may offer the most complete approach to mitochondrial health optimization. Third-party tested with Certificates of Analysis Shop MOTS-C Browse All Peptides